Invention Grant
- Patent Title: EGFR modulators and uses thereof
-
Application No.: US15708024Application Date: 2017-09-18
-
Publication No.: US10449196B2Publication Date: 2019-10-22
- Inventor: Xiao Xu , Xiaobo Wang , Long Mao , Li Zhao , Biao Xi
- Applicant: Acea Biosciences Inc.
- Applicant Address: US CA San Diego
- Assignee: ACEA Therapeutics, Inc.
- Current Assignee: ACEA Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Rimon, P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04 ; A61K45/06
Abstract:
The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
Public/Granted literature
- US20180008607A1 NOVEL EGFR MODULATORS AND USES THEREOF Public/Granted day:2018-01-11
Information query
IPC分类:
